8 Hour MAT Training Questions With
Correct Answers.
What pwas plearned pfrom pthe pearly pmethadone presearch?
A. pMethadone ptreatment pwas pcorrective, pbut ppatients pcan't ptaper pfrom pit
B. pPatients pexperienced pintoxication pfrom pmethadone psimilar pto pheroin
C. pPatients pexperienced pceiling pagonist peffects ptherefore pdid pnot phave pblockade pfrom pthe pshort- pacting
popioids
D. pMethadone ptreatment preduced pdeath, pcrime pdays, pdecreased pHIV pseroconversion, pIntravenous pdrug
puse, pand pincreased psocial pfunction p- p p p pcorrect panswer.D. pMethadone ptreatment preduced pdeath, pcrime
pdays, pdecreased pHIV pseroconversion, pIntravenous pdrug puse, pand pincreased psocial pfunction
Increasing pmortality phas pbeen pseen pin pthe pUS pdue pto pthe popioid pepidemic pcompared pto psix pother
pcountries pin pwhich pgroup?
A. pYoung padults
B. pMiddle paged pwhite pmen
C. pAfrican pAmericans
D. pMiddle paged pwhite pwomen p- p p p pcorrect panswer.B. pMiddle paged pwhite pmen
Each pof pthe pfollowing pis pa pmeans pby pwhich pa pprescriber pcould pqualify pto pobtain pthe pwaiver pneeded pto
pengage pin poffice-based ptreatment pof popioid paddiction pexcept:
A. pBoard-certified pin pAddiction pPsychiatry
B. pAt pleast p100 phours pin paddiction pmedicine ppractice pthat phas pbeen previewed pand papproved pby
pSAMHSA
C. pCompleted papproved p8-hour ptraining poffered pby pa pgroup pnamed pin pDATA p2000
D. pCompleted p8 phours pof ptraining poffered pby pthe pAmerican pMedical pAssociation
, E. pNP por pPA pwho pcompleted pthe p24 phours pof paddiction pcurriculum ptraining p- p p p pcorrect panswer.B. pAt
pleast p100 phours pin paddiction pmedicine ppractice pthat phas pbeen previewed pand papproved pby pSAMHSA
A pprovider pcompletes pthe prequired ptraining pand pis peligible pfor pthe pwaiver pto poffer poffice-based
ptreatment pof popioid pdependence. pThe pprovider ppractices pin pa pcommunity pwith pepidemic popioid
paddiction pand phas p38 popioid-dependent pindividuals pwho phave pinquired pabout pthis ptreatment pand
pasked pto pbe ptreated pwhen pthe pprovider pstarts pthe pbuprenorphine/naloxone ppractice. pWhich pof pthe
pfollowing pis pthe pappropriate pcourse pof paction:
A. pCompletion pof pthe pcourse pand psubmission pof pthe pNotification pof pIntent pform pis psufficient pto pstart
ppractice.
B. pThe pprovider pneeds pto pwait pup pto p45 pdays pto preceive ptheir pwaiver pand ptreat pup pto p30 ppatients pat
pone ptime.
C. pThe pprovider pcan papply pfor pan pextended pwaiver pto p100 pupon preceipt pof pwaiver.
D. pThe pprovider pmay ptreat pthese ppatients pwith pbuprenorphine/naloxone poff-label.
E. pThe pprovider pmay ptreat pall pof pthese pindividuals pby pcompleting pan padditional pnotification pto pthe pDEA
pof pthe purgent pneed pin pth p- p p p pcorrect panswer.B. pThe pprovider pneeds pto pwait pup pto p45 pdays pto preceive
ptheir pwaiver pand ptreat pup pto p30 ppatients pat pone ptime.
The pDrug pAddiction pTreatment pAct pof p2000 p(DATA p2000) pallows pwaivered pproviders pto pprovide pOffice
pBased pOpioid pTreatment pwhich pincludes pall pexcept:
A. pFDA papproved pmedications pfor pmaintenance por pdetoxification
B. pMedications pin pschedules pIII, pIV, por pV
C. pBuprenorphine por pBuprenorphine/naloxone
D. pMethadone p- p p p pcorrect panswer.D. pMethadone
Prescriber pare prequired punder pDATA p2000 pto pfulfill pthe pfollowing prequirements pexcept:
A. pMandatory pcounseling pof pall ppatients
B. pCompletion pof pan papproved p8-hour pwaiver pcourse
C. pCompletion pof p16 padditional pcurriculum phours pfor pNP's pand pPA's
Correct Answers.
What pwas plearned pfrom pthe pearly pmethadone presearch?
A. pMethadone ptreatment pwas pcorrective, pbut ppatients pcan't ptaper pfrom pit
B. pPatients pexperienced pintoxication pfrom pmethadone psimilar pto pheroin
C. pPatients pexperienced pceiling pagonist peffects ptherefore pdid pnot phave pblockade pfrom pthe pshort- pacting
popioids
D. pMethadone ptreatment preduced pdeath, pcrime pdays, pdecreased pHIV pseroconversion, pIntravenous pdrug
puse, pand pincreased psocial pfunction p- p p p pcorrect panswer.D. pMethadone ptreatment preduced pdeath, pcrime
pdays, pdecreased pHIV pseroconversion, pIntravenous pdrug puse, pand pincreased psocial pfunction
Increasing pmortality phas pbeen pseen pin pthe pUS pdue pto pthe popioid pepidemic pcompared pto psix pother
pcountries pin pwhich pgroup?
A. pYoung padults
B. pMiddle paged pwhite pmen
C. pAfrican pAmericans
D. pMiddle paged pwhite pwomen p- p p p pcorrect panswer.B. pMiddle paged pwhite pmen
Each pof pthe pfollowing pis pa pmeans pby pwhich pa pprescriber pcould pqualify pto pobtain pthe pwaiver pneeded pto
pengage pin poffice-based ptreatment pof popioid paddiction pexcept:
A. pBoard-certified pin pAddiction pPsychiatry
B. pAt pleast p100 phours pin paddiction pmedicine ppractice pthat phas pbeen previewed pand papproved pby
pSAMHSA
C. pCompleted papproved p8-hour ptraining poffered pby pa pgroup pnamed pin pDATA p2000
D. pCompleted p8 phours pof ptraining poffered pby pthe pAmerican pMedical pAssociation
, E. pNP por pPA pwho pcompleted pthe p24 phours pof paddiction pcurriculum ptraining p- p p p pcorrect panswer.B. pAt
pleast p100 phours pin paddiction pmedicine ppractice pthat phas pbeen previewed pand papproved pby pSAMHSA
A pprovider pcompletes pthe prequired ptraining pand pis peligible pfor pthe pwaiver pto poffer poffice-based
ptreatment pof popioid pdependence. pThe pprovider ppractices pin pa pcommunity pwith pepidemic popioid
paddiction pand phas p38 popioid-dependent pindividuals pwho phave pinquired pabout pthis ptreatment pand
pasked pto pbe ptreated pwhen pthe pprovider pstarts pthe pbuprenorphine/naloxone ppractice. pWhich pof pthe
pfollowing pis pthe pappropriate pcourse pof paction:
A. pCompletion pof pthe pcourse pand psubmission pof pthe pNotification pof pIntent pform pis psufficient pto pstart
ppractice.
B. pThe pprovider pneeds pto pwait pup pto p45 pdays pto preceive ptheir pwaiver pand ptreat pup pto p30 ppatients pat
pone ptime.
C. pThe pprovider pcan papply pfor pan pextended pwaiver pto p100 pupon preceipt pof pwaiver.
D. pThe pprovider pmay ptreat pthese ppatients pwith pbuprenorphine/naloxone poff-label.
E. pThe pprovider pmay ptreat pall pof pthese pindividuals pby pcompleting pan padditional pnotification pto pthe pDEA
pof pthe purgent pneed pin pth p- p p p pcorrect panswer.B. pThe pprovider pneeds pto pwait pup pto p45 pdays pto preceive
ptheir pwaiver pand ptreat pup pto p30 ppatients pat pone ptime.
The pDrug pAddiction pTreatment pAct pof p2000 p(DATA p2000) pallows pwaivered pproviders pto pprovide pOffice
pBased pOpioid pTreatment pwhich pincludes pall pexcept:
A. pFDA papproved pmedications pfor pmaintenance por pdetoxification
B. pMedications pin pschedules pIII, pIV, por pV
C. pBuprenorphine por pBuprenorphine/naloxone
D. pMethadone p- p p p pcorrect panswer.D. pMethadone
Prescriber pare prequired punder pDATA p2000 pto pfulfill pthe pfollowing prequirements pexcept:
A. pMandatory pcounseling pof pall ppatients
B. pCompletion pof pan papproved p8-hour pwaiver pcourse
C. pCompletion pof p16 padditional pcurriculum phours pfor pNP's pand pPA's
